Stefánsdóttir A, Johansson D, Knutson K, Lidgren L, Robertsson O. Microbiology of the infected knee arthroplasty: Report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases. Scand J Infect Dis; 2009. p. 41. (11/12):831-840. doi:10.3109/00365540903186207.
Lindberg-Larsen M, Pitter FT, Voldstedlund M, Schrøder HM, Bagger J. Microbiological diagnosis in revision of infected knee arthroplasties in Denmark. Infect Dis (Auckl) 2017;49(11-12):824–830. doi:10.1080/23744235.2017.1350878.
Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017;125(4):353–364. doi:10.1111/apm.12687.
Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007;55(1):1–7. doi:10.1016/j.jinf.2007.01.007.
Osmon DR, Berbari EF, Berendt AR. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1–e25. doi:10.1093/cid/cis803.
Sandoe JAT, Wysome J, West AP, Heritage J, Wilcox MH. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother. 2006;57(4):767–770. doi:10.1093/jac/dkl013.
Tornero E, Senneville E, Euba G. et al. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study. Clin Microbiol Infect. 2014;20(11):1219–1224. doi:10.1111/1469-0691.12721.
Sandoe JAT, Witherden IR, Cove JH, Heritage J, Wilcox MH. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol. 2003;52(7):547–550. doi:10.1099/jmm.0.05201-0.
Lam A, Rasmussen M, Thompson O. Successful outcome for patients with streptococcal prosthetic joint infections - a retrospective population-based study. Infect Dis (Auckl) 2018;50(8):593–600. doi:10.1080/23744235.2018.1449961.
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645–1654. doi:10.1056/NEJMra040181.
El Helou OC, Berbari EF, Marculescu CE. et al. Outcome of Enterococcal Prosthetic Joint Infection: Is Combination Systemic Therapy Superior to Monotherapy? Clin Infect Dis. 2008;47(7):903–909. doi:10.1086/591536.
Kheir MM, Tan TL, Higuera C. et al. Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes. J Arthroplasty. 2017;32(3):933–947. doi:10.1016/j.arth.2016.09.017.
Duijf S V, Vos FJ, Meis JF, Goosen JH. Debridement, antibiotics and implant retention in early postoperative infection with Enterococcus sp. Clin Microbiol Infect. 2015;21(5):e41–e42. doi:10.1016/j.cmi.2015.01.006.
Tornero E, Soriano A. Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR) Clin Microbiol Infect. 2015;21(5):e43–e44. doi:10.1016/j.cmi.2015.01.012.
Lora-Tamayo J, Murillo O, Iribarren JA. et al. A large multicenter study of methicillin-susceptible and methicillin-resistant staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis. 2013;56(2):182–194. doi:10.1093/cid/cis746.
Baddour LM, Wilson WR, Bayer AS. et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486. doi:10.1161/CIR.0000000000000296.
Holmberg A, Mörgelin M, Rasmussen M. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother. 2012;67(2):433–439. doi:10.1093/jac/dkr477.
Holmberg A, Rasmussen M. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms. Int J Antimicrob Agents. 2014;44(1):78–80. doi:10.1016/j.ijantimicag.2014.03.008.